Search Results (1,296)

Diabetes Mellitus is a complex metabolic disorder, primarily characterized by persistent high blood sugar levels, and it is becoming increasingly prevalent with numerous associated complications. The leaves of Cyclocarya paliurus (Batal.) Iljinskja, traditionally prepared as a tea beverage in China, is frequently used in folk medicine for managing metabolic syndromes, particularly diabetes and hyperlipidemia. However, the main active components responsible for its hypoglycemic effect and their underlying mechanisms remain unclear. The current study aimed to clarify the main chemical components of the aqueous extract of C. paliurus leaves and to explore their mechanisms of action. The primary constituents from the aqueous extract of C. paliurus leaves were isolated and identified using macroporous adsorption resin, preparative liquid chromatography, and nuclear magnetic resonance technology. The contents of these identified compounds in the leaves were quantified using HPLC. An integrated approach combining network pharmacology and molecular docking was initially used to predict the potential molecular targets and associated signaling pathways responsible for the hypoglycemic activity of the compounds, with subsequent experimental validation performed in a hyperglycemic zebrafish model. From the aqueous extract, a total of seven compounds were obtained and subsequently identified as Chlorogenic Acid (CA), Quercetin-3-O-β-D-glucuronide (Q3GA), Astragalin, 3,4-Dicaffeoylquinic Acid (3,4-DCA), Afzelin, Quercetin, and Kaempferol. Their contents in C. paliurus leaves, as determined by HPLC, were 24.88 mg/g, 30.87 mg/g, 1.21 mg/g, 1.19 mg/g, 5.24 mg/g, 2.43 mg/g, and 1.34 mg/g, respectively. Network pharmacology analysis identified AKT1, TNF, and IL1B as key targets for the hypoglycemic effects of both the aqueous extract and the seven individual compounds. These findings were further supported by RT-PCR experiments in a zebrafish model, which showed that blood glucose regulation occurs through the downregulation of TNF and IL1B and the upregulation of AKT1 protein. The aqueous extract is rich in Chlorogenic Acid, Quercetin, and their derivatives, all of which display significant hypoglycemic activity. Full article

Hyperlipidemia is a metabolic disease of significant current concern. Research has demonstrated that hyperlipidemia is a primary risk factor for cardiovascular disease (CVD). Furthermore, hyperlipidemia significantly increases the risk of intracellular lipid peroxidation, which further contributes to the development of CVD. Dietary bioactive interventions, including polysaccharides, polyphenols, and organic acids, have demonstrated significant potential in regulating lipid metabolism and preventing chronic diseases. This study investigated the hypoglycemic effects of Yongchun aged vinegar powder (YAVP) using an in vitro model. Considering that the bioactivity of dietary components is influenced by gastrointestinal transit, YAVP was first underwent simulated gastric and intestinal digestion in vitro. The resulting digests were applied to a sodium oleate-induced high-fat HepG2 cell model. The results demonstrated that digested YAVP significantly inhibited intracellular lipid accumulation in a dose-dependent manner. Specifically, YAVP intervention substantially lowered concentrations of total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C), while simultaneously elevating high-density lipoprotein cholesterol (HDL-C) levels relative to the model group. These findings suggest that YAVP retains its bioactivity after simulated digestion and exerts potent hypoglycemic effects by regulating lipid profiles in HepG2 cells, supporting its potential as a functional dietary supplement for lipid management. Full article

Background/Objectives: Obesity and type 2 diabetes are increasingly common among patients undergoing hip and knee arthroplasty and are associated with higher risks of prosthetic joint infection, impaired wound healing, and prolonged hospitalisation. Dietary carbohydrate restriction has demonstrated benefits in glycemic control and weight reduction, but its feasibility and safety in the perioperative arthroplasty population remain underexplored. This pilot study evaluated the safety, feasibility, and short-term metabolic effects of a low-carbohydrate diet supported by WhatsApp-based meal photo-logging in patients undergoing total hip or knee arthroplasty. Methods: A retrospective cohort analysis was performed on 43 patients enrolled in a carbohydrate-restricted dietary programme between 2021 and 2024. Patients submitted photographs of all meals via WhatsApp with a minimum contact frequency of four times daily, enabling real-time feedback and medication adjustment. Anthropometric and metabolic parameters, including weight, BMI, HbA1c, renal function, and lipid profile, were assessed before and after the intervention. Results: Participants (mean age 69.12 ± 7.51 years) demonstrated significant improvement across several metabolic markers. Mean weight decreased by 5.74 kg (p < 0.001), BMI by 2.26 kg/m² (p < 0.001), and HbA1c by 0.72% (p < 0.001). No episodes of severe hypoglycaemia or perioperative discharge delays related to glycemic instability were observed. Renal function remained stable, with no significant change in eGFR (p = 0.442). Among patients with available lipid data (n = 14), LDL-cholesterol and total cholesterol increased, while triglycerides showed a non-significant downward trend. Conclusions: A low-carbohydrate diet combined with high-frequency digital monitoring appears feasible and safe, achieving meaningful short-term improvements in weight and glycemic control without adverse renal or hypoglycemic events. The lipid changes observed, however, warrant cautious interpretation. These findings are hypothesis-generating, and larger prospective studies are needed to confirm the clinical impact of this approach and its relevance to perioperative optimisation. Full article

Objective: Individuals with reactive hypoglycemia (RH) may be more likely to develop obesity and type 2 diabetes, but the ability to identify RH has been hampered by the lack of clear criteria. This study used calculus-based curve parameters from a mixed macronutrient liquid meal test (MMTT) to define RH in men and women with obesity. Methods: A total of 69 non-diabetic adults aged 35 ± 8.3 years with obesity (BMI 32.3 ± 4.2 kg/m²) underwent a 4 h MMTT to define RH, and an intravenous glucose tolerance test (IVGTT) to characterize RH (via insulin sensitivity, the acute insulin response to glucose (AIRg), insulin clearance, and the disposition index). Perceived hunger and fullness were assessed by visual analog scale. Results: RH was defined using curve properties of the MMTT. A total of 19 of the 69 participants had a reactive hypoglycemic response to the MMTT. Glucose AUC and nadir were lower, timing of glucose nadir was earlier, and insulin sensitivity was higher in RH compared to non-RH. Sex (female) and race (AA) were significant predictors of RH presence. Conclusions: Among individuals with obesity, RH is characterized by greater sensitivity to insulin and greater disposition index. We introduce a novel and reproducible method to define RH using curve-based criteria from a mixed meal test integrated with gold-standard IVGTT-derived outcomes. Full article

Introduction: Recurrent hypoglycemia occurring prior to the initiation of insulin therapy is an uncommon finding at the onset of pediatric type 1 diabetes mellitus (T1D). Aim: The aim of this study was to describe an unusual presentation of T1D onset characterized by recurrent hypoglycemia in a pediatric patient and to provide an updated review of the literature on hypoglycemic episodes occurring before insulin initiation in children with new-onset T1D. Case report: We present the case of a child who exhibited recurrent fasting hypoglycemia and postprandial hyperglycemia at the onset of T1D. Clinical findings also included persistently elevated glucagon levels (66–93 pmol/L; normal values [n.v.] 3–60); markedly elevated glycated hemoglobin (98 mmol/moL); low C-peptide levels (0.05 nmol/L); and a slight positivity for antibodies to glutamic acid decarboxylase (38.3 KUI/L; n.v. < 10). Review of the literature: A narrative review of the literature was conducted using the PubMed (MEDLINE) database to identify studies reporting hypoglycemia at the onset of T1D in pediatric patients prior to insulin initiation. The search included combinations of the terms hypoglycemia, new-onset, type 1 diabetes, child, and adolescent, with an exclusion of insulin-treated cases. We also explore potential pathogenetic mechanisms underlying this unusual presentation, including alpha-cell acute damage or dysregulation and loss of intra-islet paracrine signaling. Conclusions: Among individuals with T1D onset, episodes of recurrent hypoglycemia before the initiation of insulin therapy have been reported in a few studies. The presented case expands the clinical spectrum of early T1D and suggests that early alpha-cell dysfunction may contribute to atypical glycemic patterns during disease onset. Full article

The objective of this study was to explore the effect of the assembly sequences of wall materials on the structure and properties of Antarctic krill peptide (AKP)-loaded ovalbumin (OVA)–chitosan (CS) nanoparticles (NPs). Two AKP-loaded NPs (CS/OVA-AKP and OVA/CS-AKP) were prepared by changing the sequences of OVA and CS. The results confirmed that CS/OVA-AKP had a smaller particle size (291 nm vs. 320 nm), lower polydispersity index (0.233 vs. 0.282), higher absolute zeta potential (34.4 mV vs. 32.1 mV), and higher encapsulation efficiency (81.6% vs. 75.4%) than OVA/CS-AKP. X-ray diffraction analysis confirmed that AKP was encapsulated in an amorphous state within the NPs. Fourier transform infrared spectroscopy and three-dimensional (3D) fluorescence spectroscopy revealed that electrostatic interactions, hydrogen bonding, and hydrophobic interactions were the primary driving forces for nanoparticle formation, with CS/OVA-AKP demonstrating a stronger OVA fluorescence quenching effect. Compared with OVA/CS-AKP, CS/OVA-AKP exhibited better redispersibility, and CS/OVA-AKP showed greater stability under various environmental factors (thermal treatment, salt concentration, pH, and storage time). During simulated gastrointestinal digestion, CS/OVA-AKP effectively protected AKP from gastric degradation and showed a higher AKP release rate in simulated intestinal fluid (61.1%) than OVA/CS-AKP (53.0%). The release followed the Korsmeyer–Peppas model, with OVA/CS-AKP exhibiting non-Fickian diffusion (n = 0.7500), and CS/OVA-AKP approached Case II transport (n = 0.9889), indicating erosion-controlled release behavior. CS/OVA-AKP also demonstrated higher hypoglycemic activity, with inhibition rates of 41.1%, 37.5%, and 36.1% for α-glucosidase, α-amylase, and DPP-IV, respectively. These findings underscore the important influence of wall-material assembly sequences on the structure and properties of AKP-loaded NPs, offering valuable insights for the development of bioactive peptide delivery systems. Full article

To address the limited functional diversity of traditional kombucha, this study utilized red yeast rice (RYR) as an alternative substrate and prepared three samples: black tea kombucha (KBT), black tea-red yeast rice mixed kombucha (KBL, at a 1:1 ratio), and red yeast rice kombucha (KRY). After 9 days of fermentation, KRY exhibited the lowest pH, the highest total acidity, and notable sugar metabolic activity. It exhibited in vitro inhibition rates of 82.8%, 78.2%, 70.3%, and 76.9% against cholesterol esterase, pancreatic lipase, α-glucosidase, and α-amylase, respectively, indicating potential hypoglycemic and hypolipidemic activities. In contrast, KBT maintained the strongest antioxidant capacity, with scavenging rates exceeding 90% against both 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-Azinobis-(3-ethylbenzthiazoline-6-sulphonate) (ABTS). A total of 72 volatile flavor compounds (VFCs) were identified, with 7 key compounds enriched in KRY, which enhanced its sensory acceptance and received the highest scores in color, clarity, and aroma. Microbial community analysis revealed the post-fermentation dominance of Komagataeibacter, Acetobacter, and Saccharomyces, which correlated positively with key VFCs. These findings indicate that RYR as a substrate enhances functional microbial growth, sugar metabolism, organic acid production, flavor enrichment, and in vitro inhibitory activity of enzymes associated with hypoglycemic and hypolipidemic effects. Full article

Hyperuricemia (HUA) is a metabolic disorder that can easily lead to gout or kidney disease, and it is believed that it can be treated effectively using probiotics. This study evaluated the safety, probiotic, and functional properties of Wickerhamomyces anomalus YFJ252, isolated from pickled vegetables, including its in vitro inhibitory activity against xanthine oxidase (XO) and in vivo uric acid-lowering activity in mice, using virulence factor screening, plate counting, and colorimetric assays. Meanwhile, the potential anti-HUA mechanism was also investigated using untargeted metabolomics and whole-genome analysis. The results show that YFJ252 is non-hemolytic and does not produce DNase, gelatinase, or biogenic amine. It has potential probiotic properties: 85.83% DPPH radical scavenging, 39.94% α-amylase inhibition, 35.32% α-glucosidase inhibition, 20.73% anti-inflammatory ability, and 84.15% XO inhibition capacity. Animal experiments indicated that early intake of YFJ252 could maintain serum uric acid levels at 165.08 μmol/L (p < 0.05), lower than the HUA group (212.19 μmol/L), and significantly decrease creatinine and urea nitrogen levels (p < 0.05). The hypothetical anti-HUA potential of YFJ252 might be due to the production of antioxidant, hypoglycemic, and XO-inhibitory metabolites during growth, as well as a purine-degrading pathway that the strain inherited. This study provides a theoretical basis for using W. anomalus YFJ252 as a food ingredient with preventive effects against HUA. Full article

Glibenclamide (Gli), widely used in the management of type 2 diabetes mellitus (T2DM), shows low oral bioavailability, while curcumin (Cur) is limited by poor aqueous solubility and instability. This study reports the development of a niosomal co-delivery system combining hypoglycemic and antioxidant agents to improve formulation performance for T2DM. Gli and Cur were co-encapsulated into niosomal vesicles (NIOs) using the thin-film hydration method, followed by surface coating with chitosan (CS). The formulations were characterized by dynamic light scattering, scanning transmission electron microscopy, X-ray diffraction, and Fourier-transform infrared spectroscopy, complemented by in vitro release studies under simulated gastrointestinal conditions. The prepared NIOs exhibited particle sizes between 413.5 and 576.9 nm, with encapsulation efficiency strongly dependent on formulation composition. The optimized system showed high encapsulation efficiency for both Gli (98.95 ± 0.87%) and Cur (91.09 ± 2.00%). In vitro release studies demonstrated enhanced release compared with the physical mixture, providing gastric protection and sustained intestinal delivery. Release kinetics indicated controlled drug release governed by diffusion- and erosion-based mechanisms. Both uncoated and CS-coated NIOs displayed good physical and osmotic stability, with CS coating further reducing drug leakage. These results highlight the potential of niosomal systems for efficient Gli and Cur administration in T2DM. Full article

Tartary buckwheat (Fagopyrum tataricum), a medicinal and edible crop, is valued for its richness in flavonoids and polyphenols, which confer antioxidant and hypoglycemic activities. Eurotium cristatum, a dominant fungus crucial for the quality of Fuzhuan tea, produces unique aromas and metabolites. This study developed cookies by replacing 20% of low-gluten flour with Tartary buckwheat flour that had undergone solid-state fermentation with E. cristatum followed by baking. Compared to cookies containing non-inoculated buckwheat flour, the fermented cookies contained significantly higher levels of total flavonoids (4.97 mg/g) and polyphenols (2.31 mg/g), and exhibited markedly enhanced antioxidant activity, as evidenced by a 16.4% higher ABTS radical scavenging rate and a 42.5% greater ferric reducing power. The fermented cookies also exhibited improved textural and sensory properties, a unique aroma profile characterized by pleasant floral notes, and a more homogeneous microstructure. HS-SPME-GC-MS analysis indicated that the optimized flavor resulted from the upregulation of key pleasant aroma compounds (e.g., (E)-2-nonenal, anethole) and the suppression of specific off-odor compounds (e.g., 2-ethyl-3,5-dimethylpyrazine, p-cresol). In conclusion, solid-state fermentation with E. cristatum followed by baking, effectively improves both the nutritional and sensory characteristics of Tartary buckwheat cookies, providing a viable strategy for developing novel, health-promoting bakery products with an appealing compelling flavor profile. Full article

Background/Objectives: Mori fructus polysaccharides are key bioactive components with diverse activities, but structural characterization of homogeneous fractions remains limited, hindering insights into structure–activity relationships. This study addresses this gap by isolating and characterizing a homogeneous polysaccharide (MFP-III) from M. fructus. Methods: MFP-III, representing the final gel-filtration homogeneous fraction, was purified using defined procedures: DEAE-52 cellulose chromatography followed by Sephadex G-100 gel filtration. Purity and homogeneity were validated by high-performance liquid chromatography (HPLC). Structural characteristics were analyzed via HPLC, GC-MS, FTIR, and NMR spectroscopy. Meanwhile, hypoglycemic activity of MFP-III was evaluated. Results: MFP-III (94.2 ± 2.6%) has a molecular weight of approximately 6.83 kDa, primarily composed of rhamnose, arabinose, galactose, glucose, mannose, and galacturonic acid. Its backbone structure is presumed to be →2,4)-α-L-Rhap-(1 → 4)-α-D-GalpA-(1→, with branching units potentially attached to O-4. MFP-III demonstrated significant inhibitory activity against α-glucosidase (IC₅₀ = 1.56 mg/mL) and α-amylase (IC₅₀ = 2.07 mg/mL), stronger than acarbose at equivalent concentrations. Conclusions: The findings provide preliminary insights into the hypoglycemic structure–activity relationship of MFP-III, providing data support for the development of blood glucose-lowering natural inhibitors, and offering a theoretical foundation for advancing the application of polysaccharides from other sources. Full article

Type 2 diabetes mellitus (T2DM) remains a global health challenge, necessitating novel therapeutic and dietary strategies. This study optimized hydroalcoholic extraction parameters to maximize α-amylase inhibitory activity from five African medicinal plants: Combretum glutinosum (CG), Ziziphus mauritiana (ZM), Gymnosporia senegalensis (GS), Boscia senegalensis (BS), and Citrullus colocynthis (CC). A central composite design (CCD) modeled the effects of the liquid-to-solid (L/S) ratio (5–15 mL/g) and ethanol concentration (0–100%, v/v), identifying optimal conditions at low L/S ratios (5 mL/g) and moderate-to-high ethanol concentrations (40–100%) for GS, ZM, and CG, where inhibition levels exceeded 80–98% of α-amylase activity. Extracts from CG, ZM, and GS showed the strongest inhibition (IC₅₀ values of 3.67, 9.8, and 2.25 mg/mL, respectively). Antioxidant capacities, evaluated by DPPH and FRAP assays, correlated strongly with total phenolic content (TPC), with ZM exhibiting superior DPPH (IC₅₀ = 1.94 ± 0.16 mg/mL) and FRAP (IC₅₀ = 4.34 ± 0.52 mg/mL) activities. Incorporation of optimized plant powders (3%, w/v) into bread dough significantly influenced textural and colorimetric properties. Mixture design analysis revealed that CG-rich formulations (>2%) yielding hardness exceed 6 N, while ZM–GS blends maintain 3 N, offering targeted firmness control. The addition of medicinal plants significantly increased the total phenolics content by 60% of doughs and thus caused a significant improvement in antioxidant activities. These functional enrichments suggest potential for developing hypoglycemic bakery products with improved sensory attributes. This integrative approach combining extraction optimization and food formulation offers promising avenues for natural antidiabetic agents and functional food development. Full article

Type 2 diabetes mellitus (T2DM) is a globally prevalent chronic metabolic disorder that poses severe public health risks. Synthetic hypoglycemic agents are susceptible to inducing adverse reactions, thus driving the development of natural, safe and highly effective plant-derived hypoglycemic active compounds as a research hotspot. Inhibiting the activity of α-glucosidase and α-amylase represents an effective strategy to regulate postprandial blood glucose levels. This study investigated the synergistic hypoglycemic activity of a composite (PS-PP) formed by polysaccharide (PS) and polyphenols (PP) from Ziziphus jujuba Mill. cv. Muzao and elucidated the structural basis underlying this synergistic effect. First, MPS and MPP were isolated and purified, followed by the in vitro assembly to prepare PS-PP. The hypoglycemic activities of MPS, MPP and MPS-PP were evaluated via in vitro enzyme inhibition assays, while structural characterization was conducted using GPC-MALLS, FT-IR and SEM techniques. Results demonstrated that PS-PP exerted the strongest activity under optimal conditions (0.75 mg/mL concentration, pH 4.0, 1:2 mass ratio), with IC₅₀ values of 1.14 μg/mL and 0.82 μg/mL against the two enzymes, which were superior to those of polysaccharides (15.10 and 36.06 μg/mL) and polyphenols (1.18 and 46.24 μg/mL). Structural analysis revealed that the interaction between PS and PP was primarily mediated by hydrogen bonds. PS-PP exhibited significant differences from single-component compounds in molecular weight distribution, functional group binding and surface morphology. These structural alterations were identified as the key factors contributing to its enhanced hypoglycemic efficacy. This study clarifies the synergistic hypoglycemic mechanism of MPP-PS and lays a scientific foundation for the development of natural hypoglycemic preparations and functional foods. Full article

Diabetes mellitus is a major global health burden, and plant-derived polyphenols are increasingly explored as adjuncts for metabolic control. Hence, the hypoglycaemic potential of Pinus nigra bark extract from Serbia was evaluated using complementary in silico and in vivo approaches. Major constituents reported for P. nigra bark (catechin, epicatechin, taxifolin, caffeic, ferulic, p-coumaric, protocatechuic, and syringic acids) were docked against selected metabolic targets (LXRα, LXRβ, PTP1B, and SUR1) as hypothesis-generating screening due to the frequent PAINS behaviour of small polyphenols. For in vivo assessment, normoglycaemic and alloxan-induced diabetic Wistar rats received a 7-day oral treatment with ethanol bark extract (100 mg/kg) alone or combined with metformin (100 mg/kg) or gliclazide (10 mg/kg), and fasting glycaemia, oral glucose tolerance, lipid profile, and body weight were assessed. The ethanol extract reduced glycaemia, improved glucose tolerance, and favourably modulated dyslipidaemia, with additive effects observed in combinations with metformin or gliclazide. These findings suggest activity relevant to hypoglycaemic-relevant activity of P. nigra bark extract in vivo; however, comprehensive chemical profiling, mechanistic confirmation, and safety evaluation are required before translational consideration. Full article

The Croton genus includes a diverse group of plants with remarkable potential in natural products research, particularly due to their bioactive compounds with hypoglycemic and phytochemical significance. This study examines Croton guatemalensis Lotsy, focusing on its chemical composition and its biological efficacy as a glucose-6-phosphatase inhibitor. Phytochemical analysis led to the isolation and structural elucidation of eleven compounds (1–11), including three new ent−clerodane diterpenes, designated crotoguatenoic acids C (9), D (10), and E (11). The absolute configurations of compounds 9–11 were determined by electronic circular dichroism (ECD) as (5R,8R,9R,10S)-configured ent–clerodanes. High-performance liquid chromatography–mass spectrometry (HPLC–MS/MS) revealed 25 peaks tentatively assigned to terpenoids, flavonoids, and alkaloids, highlighting the species’ chemical diversity. In vitro assays using ethanol–water extract (EWE) and isolated compounds with rat liver microsomes demonstrated inhibitory activity against glucose-6-phosphatase (G6Pase), particularly among ent–clerodane diterpenes (73–96%), with EWE and compounds 1, 4, and 11 showing the highest inhibition. Molecular docking analysis revealed strong interactions between these diterpenoids and the G6PC1 binding pocket, with binding energies comparable to chlorogenic acid (positive control). These findings position C. guatemalensis as a valuable source of bioactive diterpenoids and support the potential of ent-clerodane derivatives as natural G6Pase inhibitors for hyperglycemia management. Full article